Overview

The Safety of Nafamostat Mesylate for Patients With High Risk Bleeding Undergoing Hemodialysis: A Pilot Study

Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
Comparison nafamostat and low molecular weight heparin among dialysis patients
Phase:
N/A
Details
Lead Sponsor:
Wonju Severance Christian Hospital
Treatments:
Nafamostat